INGRAM DOUGLAS S bought SRPT
December 7, 2025 · Form 4 insider transaction
INGRAM DOUGLAS S bought 50,000 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderINGRAM DOUGLAS S
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 7, 2025
Filing dateDecember 9, 2025
Shares owned after440,307
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was granted performance-contingent restricted stock units ("Performance-Contingent RSUs"), as described in the Company's 2018 Equity Incentive Plan. Each Performance-Contingent RSU represents the right to receive one share of common stock. The Performance-Contingent RSUs are subject to service- and performance-based vesting criteria.